Research on Malignancies in the Context of HIV/AIDS (R21)

The summary for the Research on Malignancies in the Context of HIV/AIDS (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Research on Malignancies in the Context of HIV/AIDS (R21): -Purpose. The purpose of this funding opportunity announcement (FOA) is to advance our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying Human Immunodeficiency (HIV) infection or Acquired Immune Deficiency Syndrome (AIDS). Through this FOA, the NCI and NIDCR seek to encourage research in areas such as the study of the etiologic factors, cofactors, pathogenesis, and consequences of HIV-associated malignancies in [the members of] diverse populations. Research on non-AIDS defining malignancies in the context of HIV infection is also encouraged. The incidence of non-AIDS-defining malignancies (e.g., anal, skin, and lung cancers as well as Hodgkin s disease) appear to be increasing in the era of Highly Active Antiretroviral Treatment (HAART). This FOA extends to research efforts that will (i) provide information on the clinical outcomes of such cancers in the HIV-infected population and (ii) identify specific contributions resulting from HIV infection for the development and pathogenesis of these cancers. Ultimately, such efforts could inform screening approaches and therapies targeted to the HIV-infected population.
Federal Grant Title: Research on Malignancies in the Context of HIV/AIDS (R21)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-07-454
Type of Funding: Grant
CFDA Numbers: 93.121
CFDA Descriptions: Oral Diseases and Disorders Research
Current Application Deadline: Sep 07, 2010 Mult
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Sep 13, 2007
Creation Date: Dec 05, 2008
Archive Date: Oct 08, 2010
Total Program Funding:
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
NIDCR Mentoring Network to Promote a Diverse Dental, Oral and Craniofacial Research Workfo...
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparit...
Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Cl...
Building Interdisciplinary Research Careers in Women's Health (BIRCWH) (K12 Clinical Trial...
Epidemiological and Behavioral Research in Oral Health
Metagenomic Analyses of the Oral Microbiome
Phase Iii Clinical Trials in Oral Infectious Diseases
More Grants from the National Institutes of Health
Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (R01 Clinical ...
Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Mino...
Strategies for Controlled Release of HIV Vaccines (SCORE-H) (R01 Clinical Trial Not Allowe...
NINDS Program Project Grant (P01 Clinical Trial Optional)
Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial N...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com